<DOC>
	<DOCNO>NCT00190385</DOCNO>
	<brief_summary>Liver carcinoma become main complication cirrhosis . Treatment symptomatic large tumor disappoint . Regular ultrasonographic screen small ( curable ) tumor currently recommend , best periodicity unknown.This randomize trial aim compare 6-month ( current recommendation ) 3-month ultrasonographic screening .</brief_summary>
	<brief_title>Screening Hepatocellular Carcinoma Patients With Compensated Cirrhosis</brief_title>
	<detailed_description>Patients : All consecutive patient compensate HBV , HCV , alcohol hemochromatosis-related cirrhosis ( without previous clinical complication include liver cancer ) . Randomization : factorial : ultrasonography ( 3-month versus 6-month ) ; serum alfa-fetoprotein assay ( none versus 6-month ) . End point : rate small tumor ( first main criterion ) ; survival ( second main criterion ) .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Compensated cirrhosis Antecedent osmic acid synoviorthesis isotopic synoviorthesis study knee Intraarticular injection triamcinolone hexacetonide three month precede inclusion different corticoid month precede inclusion Evolutionary infectious neoplastic pathology</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Cirrhosis</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Screening</keyword>
	<keyword>Randomized</keyword>
	<keyword>HBV</keyword>
	<keyword>HCV</keyword>
	<keyword>alcohol</keyword>
	<keyword>hemochromatosis</keyword>
</DOC>